- ►annals.org JS Haas, KA Phillips, EP Gerstenberger, AC … - Annals of internal medicine, 2005 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Generic substitution is one mechanism of curtailing ... Cited by 67 - Related articles - All 4 versions
MA Fischer, J Avorn - Health Services Research, 2003 - pubmedcentral.nih.gov Objective. To calculate the financial impact of underuse of generic medications
in state Medicaid programs. Data Sources/Study Setting. State-by-state data on
Medicaid drug spending for 48 states and the District of Columbia in ... Cited by 39 - Related articles - BL Direct - All 5 versions
DA Mott, RR Cline - Medical care, 2002 - jstor.org OBJECTIVES. The first objective of this study was to examine the prevalence of
prescriptions that offer the opportunity for generic drug use (a prescription
for a multisource drug product). The second objective was to examine the ... Cited by 47 - Related articles - BL Direct - All 6 versions
MA Fischer, J Avorn - Pharmacoepidemiology and Drug Safety, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 32 - Related articles - BL Direct - All 4 versions
BF Banahan III, EM Kolassa - Archives of Internal Medicine, 1997 - archinte.highwire.org Background: Generic substitution has become a com- mon practice since the late
1970s. Because of the in- creased use of generic alternatives and concerns about
the Food and Drug Administration standards for bio- equivalency, ... Cited by 76 - Related articles - BL Direct - All 4 versions
- ►centad.org [PDF] WH Shrank, T Hoang, SL Ettner, PA Glassman, … - Archives of Internal Medicine, 2006 - Am Med Assoc Methods We analyzed pharmacy claims filled between October 1, 2001, and October
1, 2003, from a large health plan for 6 classes of chronic medications:
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, calcium channel ... Cited by 76 - Related articles - All 6 versions
DC Suh - Pharmacy World & Science, 1999 - Springer Introduction Pharmaceutical purchases, both generic and name- brand, represent
approximately 6% of total health care expenditures in the United States. While
the name-brand market averaged $77 billion in 1995, the generic market ... Cited by 21 - Related articles - All 3 versions
[CITATION] The implications of choice: prescribing generic or preferred formulary medications …
JE Murphy - Archives of Internal Medicine, 1999 - archinte.highwire.org IT WOULD BE HARD to find anyone who disagrees that all health care practitioners
should be concerned with the efficacy, safety, and cost of treatments provided
to their patients. Most would also agree that the first 2 considerations ... Cited by 24 - Related articles - BL Direct - All 4 versions
AD Federman, EA Halm, AL Siu - Medical care, 2007 - journals.lww.com Conclusions: Older patients of generalists and, to a greater extent,
cardiologists, often use brand-name drugs when generic equivalents are
available. Promoting generic prescribing among specialists and generalists ... Cited by 12 - Related articles - BL Direct - All 4 versions
